A detailed history of Apollo Management Holdings, L.P. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Apollo Management Holdings, L.P. holds 307,987 shares of MXCT stock, worth $1.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
307,987
Previous 307,987 -0.0%
Holding current value
$1.27 Million
Previous $1.21 Million 0.75%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$4.03 - $5.89 $1.24 Million - $1.81 Million
307,987 New
307,987 $1.52 Million
Q3 2021

Nov 15, 2021

BUY
$12.21 - $17.2 $2.97 Million - $4.19 Million
243,384 New
243,384 $2.97 Million

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $418M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Apollo Management Holdings, L.P. Portfolio

Follow Apollo Management Holdings, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollo Management Holdings, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Apollo Management Holdings, L.P. with notifications on news.